Interdisciplinary Panel Recommendations for Use of Negative Pressure Wound Therapy with Instillation

On-Demand Webcast
FACULTY

Elizabeth Ann Faust, RN, MSN, CRNP, CWS, CWOCN-AP
Wound, Ostomy, Continence Specialist
Reading Hospital
Tower Health System
Reading, Pennsylvania

Paul J. Kim, DPM, MS
Professor of Plastic Surgery
Professor of Orthopedic Surgery
Medical Director, Wound Program
Clements University Hospital
University of Texas Southwestern
Dallas, Texas

Mary Anne Obst, RN, BSN, CWON, CCRN
Complex Abdomen Specialist
Regions Hospital
Scandia, Minnesota

PROVIDER STATEMENT

In support of improving patient care, this activity has been planned and implemented by North American Center for Continuing Medical Education (NACCME) and the Wound Healing Society. NACCME is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC) to provide continuing education for the healthcare team.

For questions regarding this educational activity, please call 609-371-1137 or email info@naccme.com.

INTENDED LEARNERS

This activity is designed for physicians, podiatrists, physical therapists, and nurses involved in the treatment of patients with chronic wounds.

LEARNING OBJECTIVES

After participating in this activity, participants should be better able to:

  • Review available evidence and recommendations for managing wounds treated with NPWTi-d
  • Compare the safety, efficacy, and effectiveness of NPWTi-d and other irrigation techniques on patient outcomes
  • Explore panel recommendations on the appropriate use of NPWTi
  • Develop a team approach throughout to encourage a seamless transition of therapy usage knowledge between various departments and specialties
CLAIMING CREDIT

To be eligible for credit, participants must complete the online activity, a post-test assessment, and the evaluation by November 30, 2020. Upon completing the activity, there will be instructions on how to print a certificate or other documentation of credit.

Release Date: June 11, 2019
Expiration Date: November 30, 2020
Estimated Time to Complete: 1 hour

There is no fee associated with this activity.

COMMERCIAL SUPPORT

NACCME would like to thank the following company who has supported the "Interdisciplinary Panel Recommendations for Use of Negative Pressure Wound Therapy with Instillation" through educational grants and/or in-kind support: KCI an Acelity Company

CONTINUING EDUCATION

    In support of improving patient care, NACCME is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

PHYSICIANS

NACCME designates this live activity for a maximum of 1.0 AMA PRA Category 1 Credit™.

Physicians should claim only the credit commensurate with the extent of their participation in the activity.

NURSING

This continuing nursing education activity awards 1.0 contact hour.

Provider approved by the California Board of Registered Nursing, Provider #13255 for 1.0 contact hour.

PHYSICIAN ASSISTANTS

NACCME has been authorized by the American Academy of PAs  (AAPA)  to  award  AAPA  Category  1  CME  credit  for activities planned in accordance with the AAPA CME Criteria. This activity is designated for 1.0 AAPA Category 1 credit. PAs should only claim credit commensurate with the extent of their participation.

PODIATRY

North American Center for Continuing Medical Education, LLC (NACCME) is approved by the Council on Podiatric Medical Education as a provider of continuing education in podiatric medicine. NACCME has approved this activity for a maximum of 1.0 continuing education contact hour.

USE OF PROPRIETARY NAMES

This continuing medical education activity may include device or medicine brand names for participant clarity purposes only, due to the presence of different branded versions of the same product. No product promotion or recommendation should be inferred.

UNAPPROVED AND/OR INVESTIGATIONAL USES OF DRUGS AND DEVICES

This activity may contain information about experimental and other uses of drugs or devices that are not currently approved by the European Medicines Agency (EMA) of the European Union or the Food and Drug Administration (FDA) of the United States. Participants are strongly encouraged to consult approved product labeling for any drug or device mentioned in this activity before use. The opinions expressed during this activity are the opinions of the respective authors, presenters or moderators and do not necessarily reflect the opinions of NACCME.

DISCLAIMERS

The material presented and related discussions are not intended to be medical advice, and the presentation or discussion of such material is not intended to create and does not establish a physician-patient relationship. Medical advice of any nature should be sought from an individual’s own physician.

Neither NACCME nor any of its subsidiaries or affiliates is affiliated with, or formally endorsed by a medical society.

The opinions expressed in this educational activity are those of the faculty and are not attributable to NACCME or HMP. Clinical judgment must guide each professional in weighing the benefits of treatment against the risk of toxicity. Dosages, indications, and methods of use for products referred to in this activity are not necessarily the same as indicated in the package insert for each product, may reflect the clinical experience of the presenters, and may be derived from the professional literature or other clinical sources. Consult complete prescribing information before administering.

DISCLOSURE OF RELEVANT FINANCIAL RELATIONSHIPS

NACCME, LLC is an independent provider(s) of continuing medical education. NACCME, LLC has no proprietary or financial interest in medical or healthcare products over which the FDA (USA) or EMA (EU) has regulatory authority.

NACCME, LLC assures that all educational materials are reviewed to ensure for the absence of commercial bias, fair balance, scientific objectivity, and levels of evidence. The educational activity will not be influenced by commercial organizations and will not conflict with any other scheduled educational activities.

According to the disclosure policy of NACCME, faculty, editors, managers, and other individuals who are in a position to control content are required to disclose any relevant financial relationships with relevant commercial companies related to this activity. All relevant conflicts of interest that are identified are reviewed for potential conflicts of interest. If a conflict is identified, it is the responsibility of NACCME to initiate a mechanism to resolve the conflict(s). The existence of these interests or relationships is not viewed as implying bias or decreasing the value of the presentation.

All educational materials are reviewed for fair balance, scientific objectivity of studies reported, and levels of evidence.

Clinical Reviewers

Daniel Federman, MD, FACP
Professor of Medicine
Yale University School of Medicine
Associate Chief of Medicine
VA Connecticut Healthcare System
West Haven, CT

 

Planning Committee

Elizabeth Ann Faust, RN, MSN, CRNP, CWS, CWOCN-AP; Daniel Federman, MD, FACP; Paul J. Kim, DPM, MS; Mary Anne Obst, RN, BSN, CWON, CCRN; Susie Seaman, NP; and Chris Bolwell, Marissa Grossman, Tiffney Oliver, and Randy Robbin of NACCME.

Nurse Planner: Susie Seaman, NP, MSN, CWOCN, Infectious Disease Consultants/San Diego Infusion Center, San Diego, CA

 

The faculty has reported the following:

Ms. Faust: Consultant–KCI an Acelity Company; Speakers’ Bureau–KCI an Acelity Company

Dr. Kim: Consultant–KCI an Acelity Company, Integra LifeSciences Corporation, Kai Research, Microbion Inc; Grant/Research Support–KCI an Acelity Company, Integra LifeSciences Corporation; Speakers’ Bureau– KCI an Acelity Company, Integra LifeSciences Corporation

Ms. Obst: Consultant–KCI an Acelity Company; Speakers’ Bureau–KCI an Acelity Company

Ms. Seaman: Speakers’ Bureau–Next Science

Dr. Federman has disclosed no relevant financial relationships with any commercial interests.

Ms. Oliver and Mr. Robbin have disclosed no relevant financial relationships with any commercial interests.

Mr. Bolwell is a shareholder of GlaxoSmithKline. GlaxoSmithKline is not supporting this activity, nor does any content relate to their product/service.

Ms. Grossman is a shareholder of Stabiliz Orthopaedics. Her spouse is an officer and board member of Stabliliz Orthopaedics. Stabiliz Orthopaedics is not supporting this activity, nor does any content relate to their product/service.

NACCME requires faculty to inform participants whenever off-label/unapproved uses of drugs and/or devices are discussed in their presentations.

The faculty have disclosed that no off-label/unapproved uses of drugs and/or devices will be discussed in the presentations.

ADA STATEMENT

North American Center for Continuing Medical Education (NACCME) complies with the legal requirements of the Americans with Disabilities Act and the rules and regulations thereof. If any participant in this educational activity is in need of accommodations, please call 609-371-1137.

PRIVACY POLICY

NACCME protects the privacy of personal and other information regarding participants, educational partners, and joint sponsors. NACCME and our joint sponsors will not release personally identifiable information to a third party without the individual’s consent, except such information as is required for reporting purposes to the appropriate accrediting agency.

NACCME maintains physical, electronic, and procedural safeguards that comply with federal regulations to guard your nonpublic personal information.

Copyright © 2019 by North American Center for Continuing Medical Education, LLC. All rights reserved. No part of this accredited continuing education activity may be reproduced or transmitted in any form or by any means, electronic or mechanical, without first obtaining permission from North American Center for Continuing Medical Education. The opinions expressed in this educational activity are those of the faculty and are not attributable to NACCME. Clinical judgment must guide each professional in weighing the benefits of treatment against the risk of toxicity. Dosages, indications, and methods of use for products referred to in this activity are not necessarily the same as indicated in the package insert for each product, may reflect the clinical experience of the presenters, and may be derived from the professional literature or other clinical sources. Consult complete prescribing information before administering.

Access Webcast
Post-Test
Evaluation
Certificate
1.00 CME
1.00 CNE
1.00 CPME
1.00 Participation